Lanreotide Injection
92 interactions 53 cited referencesLanreotide injection is used to treat people with acromegaly (condition in which the body produces too much growth hormone, causing enlargement of the hands, feet, and facial features; joint pain; and other symptoms) who have not successfully, or cannot be treated with surgery or radiation. Lanreotide injection is also… Read the full Lanreotide Injection drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Lanreotide Injection Abemaciclib Verzenio Altered exposure to CYP3A4 substrate Details Lanreotide Injection Acalabrutinib Calquence Altered exposure to CYP3A4 substrate Details Lanreotide Injection Acarbose Prandase® An increased risk of hypoglycemia and impaired glucose regulation Details Lanreotide Injection Albiglutide An increased risk of hypoglycemia and impaired glucose regulation Details Lanreotide Injection Alfentanil Altered exposure to CYP3A4 substrate Details Lanreotide Injection Alogliptin Nesina An increased risk of hypoglycemia and impaired glucose regulation Details Lanreotide Injection Astemizole Altered exposure to CYP3A4 substrate Details Lanreotide Injection Axitinib Inlyta Altered exposure to CYP3A4 substrate Details Lanreotide Injection Bosutinib Bosulif Altered exposure to CYP3A4 substrate Details Lanreotide Injection Brigatinib Alunbrig Altered exposure to CYP3A4 substrate Details Lanreotide Injection Canagliflozin Invokana An increased risk of hypoglycemia and impaired glucose regulation Details Lanreotide Injection Ceritinib Zykadia Altered exposure to CYP3A4 substrate Details Lanreotide Injection Chlorpropamide Diabinese® An increased risk of hypoglycemia and impaired glucose regulation Details Lanreotide Injection Cisapride Propulsid® Altered exposure to CYP3A4 substrate Details Lanreotide Injection Clindamycin ANTIROBE Altered exposure to CYP3A4 substrate Details Lanreotide Injection Cobimetinib Cotellic Altered exposure to CYP3A4 substrate Details Lanreotide Injection Colchicine Colcrys Altered exposure to CYP3A4 substrate Details Lanreotide Injection Conivaptan Vaprisol Altered exposure to CYP3A4 substrate Details Lanreotide Injection Copper Cu 64 Dotatate Decreased copper Cu 64 dotatate efficacy Details Lanreotide Injection Crizotinib Xalkori Altered exposure to CYP3A4 substrate Details Lanreotide Injection Cyclosporine Atopica Decrease the relative bioavailability of cycloSPORINE Details Lanreotide Injection Dapagliflozin Farxiga An increased risk of hypoglycemia and impaired glucose regulation Details Lanreotide Injection Dasatinib Phyrago Altered exposure to CYP3A4 substrate Details Lanreotide Injection Dihydroergotamine Brekiya Altered exposure to CYP3A4 substrate Details Lanreotide Injection Docetaxel Beizray Altered exposure to CYP3A4 substrate Details Lanreotide Injection Dofetilide Tikosyn Altered exposure to CYP3A4 substrate Details Lanreotide Injection Dronedarone Multaq Altered exposure to CYP3A4 substrate Details Lanreotide Injection Dulaglutide Trulicity An increased risk of hypoglycemia and impaired glucose regulation Details Lanreotide Injection Empagliflozin Glyxambi® (as a combination product containing Empagliflozin and Linagliptin) An increased risk of hypoglycemia and impaired glucose regulation Details Lanreotide Injection Entrectinib Rozlytrek Altered exposure to CYP3A4 substrate Details Lanreotide Injection Ergotamine Ergomar Altered exposure to CYP3A4 substrate Details Lanreotide Injection Ertugliflozin Steglatro An increased risk of hypoglycemia and impaired glucose regulation Details Lanreotide Injection Everolimus Afinitor Altered exposure to CYP3A4 substrate Details Lanreotide Injection Exenatide Bydureon An increased risk of hypoglycemia and impaired glucose regulation Details Lanreotide Injection Fentanyl Altered exposure to CYP3A4 substrate Details Lanreotide Injection Flibanserin Addyi Altered exposure to CYP3A4 substrate Details Lanreotide Injection Gallium Ga 68 Dotatate Reduced efficacy of gallium Ga 68 dotatate Details Lanreotide Injection Gallium Ga 68 Dotatoc Decreased gallium Ga 68 dotatoc efficacy Details Lanreotide Injection Glimepiride Amaryl An increased risk of hypoglycemia and impaired glucose regulation Details Lanreotide Injection Glipizide Glucotrol An increased risk of hypoglycemia and impaired glucose regulation DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist